论文部分内容阅读
异基因骨髓移植的成就,如今已得到全世界的公认。对于这一点最好的证明是:异基因骨髓移植的主要奠基人E.D.托马斯于1990年获得了诺贝尔奖金。作为一种有效的临床医疗技术,非血缘关系提供者骨髓移植已在一些先进国家得到应用。北京医科大学血液病研究所是我国异体骨髓移植经验最多、技术水平与成功率高最的单位。笔者于最近访问了血液研究所所长陆道培教授。王:不久前,在中国人民大学,学生们纷纷自发地捐献骨髓,以挽救一位年轻女教师的生命。在北京医科大学,仅6月5日中午,就有640人登记捐献骨髓,积极支持非血缘关系骨髓移植提供者登记活动。
The achievements of allogeneic bone marrow transplantation have now been recognized all over the world. The best proof of this is that E.D. Thomas, the founder of allogeneic bone marrow transplantation, won a Nobel Prize in 1990. As an effective clinical technology, non-blood donor bone marrow transplantation has been applied in some advanced countries. Institute of Hematology, Beijing Medical University is the most experienced allogeneic bone marrow transplantation, the highest level of technology and success rate of the unit. The author recently visited Professor Lu Daopei, director of the Institute of Blood. Wang: Not long ago, at Renmin University of China, students spontaneously donated bone marrow to save the lives of a young female teacher. At Beijing Medical University, at noon on June 5, 640 people registered for bone marrow donation and actively supported the registration of non-related bone marrow transplant providers.